Your browser doesn't support javascript.
loading
Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect® MDS/AML Disease Registry.
Pollyea, Daniel A; George, Tracy I; Abedi, Mehrdad; Bejar, Rafael; Cogle, Christopher R; Foucar, Kathryn; Garcia-Manero, Guillermo; Grinblatt, David L; Komrokji, Rami S; Maciejewski, Jaroslaw P; Revicki, Dennis A; Roboz, Gail J; Savona, Michael R; Scott, Bart L; Sekeres, Mikkael A; Thompson, Michael A; Kurtin, Sandra E; Louis, Chrystal U; Nifenecker, Melissa; Flick, E Dawn; Swern, Arlene S; Kiselev, Pavel; Steensma, David P; Erba, Harry P.
Afiliación
  • Pollyea DA; Department of Medicine Division of Hematology University of Colorado Aurora Colorado USA.
  • George TI; University of Utah and ARUP Laboratories Salt Lake City Utah USA.
  • Abedi M; University of California Davis Sacramento California USA.
  • Bejar R; Moores Cancer Center University of California San Diego Health La Jolla California USA.
  • Cogle CR; University of Florida Gainesville Florida USA.
  • Foucar K; University of New Mexico Health Sciences Center Albuquerque New Mexico USA.
  • Garcia-Manero G; MD Anderson Cancer Center University of Texas Houston Texas USA.
  • Grinblatt DL; NorthShore University Health System Evanston Illinois USA.
  • Komrokji RS; H. Lee Moffitt Cancer Center Tampa Florida USA.
  • Maciejewski JP; Cleveland Clinic Foundation Cleveland Ohio USA.
  • Revicki DA; Evidera Bethesda Maryland USA.
  • Roboz GJ; Weill Cornell College of Medicine New York New York USA.
  • Savona MR; Vanderbilt-Ingram Cancer Center Vanderbilt University School of Medicine Nashville Tennessee USA.
  • Scott BL; Fred Hutchinson Cancer Research Center Seattle Washington USA.
  • Sekeres MA; Cleveland Clinic Foundation Cleveland Ohio USA.
  • Thompson MA; Advocate Aurora Health Advocate Aurora Research Institute Milwaukee Wisconsin USA.
  • Kurtin SE; University of Arizona Cancer Center Tucson Arizona USA.
  • Louis CU; Bristol-Myers Squibb Summit New Jersey USA.
  • Nifenecker M; Bristol-Myers Squibb Summit New Jersey USA.
  • Flick ED; Bristol-Myers Squibb San Francisco California USA.
  • Swern AS; Bristol-Myers Squibb Summit New Jersey USA.
  • Kiselev P; Bristol-Myers Squibb Summit New Jersey USA.
  • Steensma DP; Dana-Farber Cancer Institute Boston Massachusetts USA.
  • Erba HP; Duke University Durham North Carolina USA.
EJHaem ; 1(1): 58-68, 2020 Jul.
Article en En | MEDLINE | ID: mdl-35847712
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline Idioma: En Revista: EJHaem Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline Idioma: En Revista: EJHaem Año: 2020 Tipo del documento: Article